US FDA approved Medtronic PLC's HeartWareHVAD left-ventricular assist device system as a "destination therapy" for patients with advanced heart failure who are not candidates for heart transplants.
The approval will allow Medtronic to market HVAD to the same population eligible for Abbott Laboratories Inc.'s HeartMate II...





